We found that FGFR2+ hematopoietic stem cell (HSC)-derived fibrocytes could be induced by ESCC cells, recruited into tumor xenografts, and differentiated into functional CAFs. This evidence concerns the gene FGFR2 and esophageal squamous cell carcinoma.